Return to homepagePandemic Pact

An International Multicenter, Adaptive, Randomized Double-Blind, PlaceboControlled Trial of the Safety, Tolerability and Efficacy of AntiCoronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Hospitalized Patients at Onset of Clinical Progression of COVID-19

  • Funded by Indian Council of Medical Research (ICMR), National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $564,912

  • Funder

    Indian Council of Medical Research (ICMR), National Institutes of Health (NIH)

  • Principal Investigator

    Dr. Aparna Mukherjee

  • Research Location

    India

  • Lead Research Institution

    Indian Council of Medical Research (ICMR)

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Clinical trial (unspecified trial phase)

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Randomized Controlled Trial

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract